Full Text View
Tabular View
Contacts and Locations
No Study Results Posted
Related Studies
Open Label Study Investigating Safety and Efficacy of NPL2009 50 mg - 150 mg on Prepulse Inhibition Tests and Continuous Performance Tasks, Adults With Fragile X Syndrome
This study has been completed.
Study NCT00637221.   Last updated on May 2, 2008.
Information provided by Neuropharm
Please refer to this study by its ClinicalTrials.gov identifier: NCT00637221
Locations
United States, California
MIND Institute
Sacramento, California, United States, 95817
United States, Illinois
Rush University Medical Centre
Chicago, Illinois, United States, 60612
Sponsors and Collaborators
Neuropharm
Investigators
Study Director: Mike Snape, PhD Neuropharm Ltd




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services